De novo vitamin D supplement use post-diagnosis is associated with breast cancer survival
ConclusionsIn this large national breast cancer cohort, de novo vitamin D use post-diagnosis was found to be associated with a reduction in breast cancer-specific mortality. Vitamin D, therefore, has the potential as a non-toxic and inexpensive agent to improve survival in breast cancer patients. Findings support the need for RCTs exploring the effect of vitamin D supplementation on breast cancer survival.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Databases & Libraries | Epidemiology | Ireland Health | Laboratory Medicine | Study | Toxicology | Vitamin D | Vitamins